{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:02:40Z","timestamp":1790740960822,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tranon.2026.102955","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:27:38Z","timestamp":1785738458000},"page":"102955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Amplicon-based DNA and RNA unified NGS for enhanced fusion variant detection in suboptimal real-world NSCLC FFPE specimens"],"prefix":"10.1016","volume":"72","author":[{"given":"Qin","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyi","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yincong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tranon.2026.102955_bib0001","first-page":"139","article-title":"Lung cancer incidence and mortality in China: updated statistics and an overview of temporal trends from 2000 to 2016","volume":"2","author":"Zheng","year":"2022","journal-title":"J. Natl. Cancer Cent."},{"issue":"6","key":"10.1016\/j.tranon.2026.102955_bib0002","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.21.01626","article-title":"Targeted therapies for lung cancer patients with oncogenic driver molecular alterations","volume":"40","author":"Tan","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"10299","key":"10.1016\/j.tranon.2026.102955_bib0003","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.tranon.2026.102955_bib0004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.celrep.2018.03.050","article-title":"Driver fusions and their implications in the development and treatment of Human cancers","volume":"23","author":"Gao","year":"2018","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.tranon.2026.102955_bib0005","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1078-0432.CCR-21-3597","article-title":"Updated integrated analysis of the efficacy and safety of Entrectinib in patients with NTRK fusion-positive solid tumors","volume":"28","author":"Demetri","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.tranon.2026.102955_bib0006","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1200\/JCO.22.00393","article-title":"Selpercatinib in patients with RET fusion-positive non-small-cell lung cancer: updated safety and efficacy from the registrational LIBRETTO-001 phase I\/II trial","volume":"41","author":"Drilon","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.102955_bib0007","article-title":"Larotrectinib for newly diagnosed infantile fibrosarcoma and other pediatric NTRK fusion-positive solid tumors (Children's Oncology Group ADVL1823)","author":"Laetsch","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.tranon.2026.102955_bib0008","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1200\/JCO.2017.75.5587","article-title":"Phase II study of Crizotinib in East Asian patients with ROS1-positive advanced non-small-cell lung cancer","volume":"36","author":"Wu","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.tranon.2026.102955_bib0009","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S1470-2045(24)00441-8","article-title":"Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial","volume":"25","author":"Wolf","year":"2024","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2026.102955_bib0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14737159.2021.1920399","article-title":"Targeted RNA-sequencing for the evaluation of gene fusions in lung tumors: current status and future prospects","volume":"21","author":"Wagener-Ryczek","year":"2021","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"15","key":"10.1016\/j.tranon.2026.102955_bib0011","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1158\/1078-0432.CCR-19-0225","article-title":"High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with No mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden","volume":"25","author":"Benayed","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.tranon.2026.102955_bib0012","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtho.2020.10.156","article-title":"Potential unreliability of uncommon ALK, ROS1, and RET genomic breakpoints in predicting the efficacy of targeted therapy in NSCLC","volume":"16","author":"Li","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"11","key":"10.1016\/j.tranon.2026.102955_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.42970","article-title":"Actionable structural variant detection via RNA-NGS and DNA-NGS in patients with advanced non-small cell lung cancer","volume":"7","author":"Owen","year":"2024","journal-title":"JAMa Netw. Open."},{"issue":"1","key":"10.1016\/j.tranon.2026.102955_bib0014","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-99541-4","article-title":"MET exon 14 skipping mutations in non-small-cell lung cancer a 3 years screening experience","volume":"15","author":"Dhiab","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.tranon.2026.102955_bib0015","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jtho.2020.01.019","article-title":"Optimizing mutation and fusion detection in NSCLC by sequential DNA and RNA sequencing","volume":"15","author":"Cohen","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102955_bib0016","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13046-017-0591-4","article-title":"High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods","volume":"36","author":"Su","year":"2017","journal-title":"J. Exper. Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2026.102955_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/srep26732","article-title":"The minimal amount of starting DNA for Agilent's hybrid capture-based targeted massively parallel sequencing","volume":"6","author":"Chung","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.tranon.2026.102955_bib0018","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2144\/000114133","article-title":"Library construction for next-generation sequencing: overviews and challenges","volume":"56","author":"Head","year":"2014","journal-title":"BioTechniques"},{"issue":"1","key":"10.1016\/j.tranon.2026.102955_bib0019","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/cas.14714","article-title":"Suitability of transbronchial brushing cytology specimens for next-generation sequencing in peripheral lung cancer","volume":"112","author":"Furuya","year":"2021","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.tranon.2026.102955_bib0020","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1111\/cas.14112","article-title":"Small lung tumor biopsy samples are feasible for high quality targeted next generation sequencing","volume":"110","author":"Kage","year":"2019","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.tranon.2026.102955_bib0021","article-title":"Suitability of bronchoscopic biopsy tissue samples for next-generation sequencing","volume":"11","author":"Murakami","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"10.1016\/j.tranon.2026.102955_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098187","article-title":"Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue","volume":"9","author":"Hedegaard","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.tranon.2026.102955_bib0023","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/pin.12969","article-title":"Evaluation of DNA and RNA quality from archival formalin-fixed paraffin-embedded tissue for next-generation sequencing - retrospective study in Japanese single institution","volume":"70","author":"Fujii","year":"2020","journal-title":"Pathol. Int."},{"issue":"12","key":"10.1016\/j.tranon.2026.102955_bib0024","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/pin.13385","article-title":"Influence of formalin fixation duration on RNA quality and quantity from formalin-fixed paraffin-embedded hepatocellular carcinoma tissues","volume":"73","author":"Amemiya","year":"2023","journal-title":"Pathol. Int."},{"issue":"11","key":"10.1016\/j.tranon.2026.102955_bib0025","first-page":"801","article-title":"Chinese expert consensus on the clinical practice of non-small cell lung cancer fusion gene detection based on RNA-based NGS]","volume":"26","year":"2023","journal-title":"Zhongguo Fei. Ai. Za Zhi."},{"issue":"1","key":"10.1016\/j.tranon.2026.102955_bib0026","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1373\/clinchem.2019.308833","article-title":"Simultaneous detection of gene fusions and base mutations in cancer tissue biopsies by sequencing dual nucleic acid templates in unified reaction","volume":"66","author":"Song","year":"2020","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.tranon.2026.102955_bib0027","first-page":"70","article-title":"Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements","volume":"3","author":"Teixid\u00f3","year":"2014","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.tranon.2026.102955_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/757490","article-title":"Targeted resequencing reveals ALK fusions in non-small cell lung carcinomas detected by FISH, immunohistochemistry, and real-time RT-PCR: a comparison of four methods","author":"Tuononen","year":"2013","journal-title":"BioMed. Res. Int."},{"issue":"8","key":"10.1016\/j.tranon.2026.102955_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070839","article-title":"Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.tranon.2026.102955_bib0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41571-020-0377-z","article-title":"MET-dependent solid tumours \u2014 molecular diagnosis and targeted therapy","volume":"17","author":"Guo","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2026.102955_bib0031","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1200\/JCO.2017.76.2294","article-title":"Impact of EML4-ALK variant on resistance mechanisms and clinical outcomes in ALK-positive lung cancer","volume":"36","author":"Lin","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102955_bib0032","doi-asserted-by":"crossref","first-page":"310","DOI":"10.32074\/1591-951X-1015","article-title":"RNA-based next-generation sequencing in non-small cell lung cancer patients: data from Campania, Italy","volume":"116","author":"Pisapia","year":"2024","journal-title":"Pathologica"},{"issue":"13","key":"10.1016\/j.tranon.2026.102955_bib0033","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/pgs-2021-0048","article-title":"Methods for actionable gene fusion detection in lung cancer: now and in the future","volume":"22","author":"Pisapia","year":"2021","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.tranon.2026.102955_bib0034","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/jclinpath-2021-207825","article-title":"Reference standards for gene fusion molecular assays on cytological samples: an international validation study","volume":"76","author":"Malapelle","year":"2023","journal-title":"J. Clin. Pathol."},{"issue":"11","key":"10.1016\/j.tranon.2026.102955_bib0035","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/cncy.21899","article-title":"ALK and ROS1 testing on lung cancer cytologic samples: perspectives","volume":"125","author":"Pisapia","year":"2017","journal-title":"Cancer Cytopathol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:42:14Z","timestamp":1790739734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326002913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"alternative-id":["S1936523326002913"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102955","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amplicon-based DNA and RNA unified NGS for enhanced fusion variant detection in suboptimal real-world NSCLC FFPE specimens","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102955"}}